Image pharmaphorum Editor News Novo expands type 1 diabetes R&D Company will also focus on serious chronic diseases News Moderna and Merck expand partnership to develop new cancer v... Moderna and Merck & Co have expanded their partnership to develop and commercialise novel personalised messenger RNA (mRNA) cancer vaccines. Sales & Marketing Sponsored Engaging with HCPS: what do HCPs want from medical meetings? News Major study to hopefully lead to reduced animal testing by d... A groundbreaking analysis of how well animal studies predict human safety will lead to reduced animal testing and better clinical results for patients, it is hoped. Load more results
News Moderna and Merck expand partnership to develop new cancer v... Moderna and Merck & Co have expanded their partnership to develop and commercialise novel personalised messenger RNA (mRNA) cancer vaccines.
News Major study to hopefully lead to reduced animal testing by d... A groundbreaking analysis of how well animal studies predict human safety will lead to reduced animal testing and better clinical results for patients, it is hoped.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
